Full text loading...
Chapter 55 : Improved Diagnostics in Microbiology: Developing a Business Case for Hospital Administration
Health care in the United States has seen dramatic changes over the last decade, including an increasing emphasis on the cost of delivering care. Although it has been estimated that approximately two-thirds of health care decisions are based on laboratory results (Silverstein M, An approach to medical errors and patient safety in laboratory sciences, White paper presented at Quality Institute Conference, 23 January 2003), according to the Congressional Budget Office, the laboratory accounts for only 4% of health care expenditures (1, 2). Nonetheless, this amount approaches $60 billion annually and is constantly a target for reduction. Thus, in this era of Accountable Care, hospital administrators are facing significant revenue shrinkage from all payers. As revenues dry up, so does internal funding for new capital initiatives and internal competition for scarce capital dollars becomes fierce.